Products for Research Use Only
RegisterLogin

Nurulimab

CAT: 0804-HY-P99760-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99760-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma[1].
CAS Number
2168561-20-2
Product Name Alternative
BCD-145
UNSPSC
12352203
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nurulimab.html
Purity
95.00
Solubility
10 mM in DMSO
Smiles
[Nurulimab]
Molecular Weight
(143.78 kDa)
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 34, No. 1, 2020.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
E40YR1589Nurulimab
592051Nurulimab (CTLA4)
GTR18337660-01Nurulimab Antibody
HB651056-01Research Grade Nurulimab
E55B0402Nurulimab (Reference antibody)
MBS1586382-01Nurulimab ELISA Kit
ICH5717-10mgNurulimab Biosimilar - Research Grade
GTR18780203-01(Nurulimab) Biosimilar Reference Antibody
ABS-229-100ugNurulimab Biosimilar, Research Grade
GTR18697818-01Nurulimab Human Monoclonal Antibody

Popular Products